rs201278114

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM5BP4_Moderate

The NM_000256.3(MYBPC3):​c.13G>T​(p.Gly5Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000152 in 1,444,702 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G5R) has been classified as Pathogenic.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.000015 ( 0 hom. )

Consequence

MYBPC3
NM_000256.3 missense

Scores

6
14

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:6

Conservation

PhyloP100: 1.88
Variant links:
Genes affected
MYBPC3 (HGNC:7551): (myosin binding protein C3) MYBPC3 encodes the cardiac isoform of myosin-binding protein C. Myosin-binding protein C is a myosin-associated protein found in the cross-bridge-bearing zone (C region) of A bands in striated muscle. MYBPC3 is expressed exclusively in heart muscle and is a key regulator of cardiac contraction. Mutations in this gene are a frequent cause of familial hypertrophic cardiomyopathy. [provided by RefSeq, May 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM5
Other missense variant is known to change same aminoacid residue: Variant chr11-47352635-C-G is described in Lovd as [Pathogenic].
BP4
Computational evidence support a benign effect (MetaRNN=0.2145879).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
MYBPC3NM_000256.3 linkuse as main transcriptc.13G>T p.Gly5Trp missense_variant 1/35 ENST00000545968.6 NP_000247.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
MYBPC3ENST00000545968.6 linkuse as main transcriptc.13G>T p.Gly5Trp missense_variant 1/355 NM_000256.3 ENSP00000442795 P4Q14896-1
MYBPC3ENST00000399249.6 linkuse as main transcriptc.13G>T p.Gly5Trp missense_variant 1/345 ENSP00000382193 A2
MYBPC3ENST00000544791.1 linkuse as main transcriptc.13G>T p.Gly5Trp missense_variant, NMD_transcript_variant 1/275 ENSP00000444259

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD3 exomes
AF:
0.00000431
AC:
1
AN:
231870
Hom.:
0
AF XY:
0.00000790
AC XY:
1
AN XY:
126622
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000945
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000152
AC:
22
AN:
1444702
Hom.:
0
Cov.:
30
AF XY:
0.0000167
AC XY:
12
AN XY:
718662
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000154
Gnomad4 OTH exome
AF:
0.0000838
GnomAD4 genome
Cov.:
32
Bravo
AF:
0.00000378

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hypertrophic cardiomyopathy Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpMar 22, 2019This sequence change replaces glycine with tryptophan at codon 5 of the MYBPC3 protein (p.Gly5Trp). The glycine residue is moderately conserved and there is a large physicochemical difference between glycine and tryptophan. This variant is not present in population databases (ExAC no frequency). This variant has been observed in an individual affected with hypertrophic cardiomyopathy, however this individual carried a likely pathogenic variant in a different gene (PMID: 28790153). ClinVar contains an entry for this variant (Variation ID: 217839). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: Deleterious; PolyPhen-2: Possibly Damaging; Align-GVGD: Class C1). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. 5 -
Uncertain significance, criteria provided, single submitterclinical testingAll of Us Research Program, National Institutes of HealthOct 02, 2023This missense variant replaces glycine with tryptophan at codon 5 of the MYBPC3 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in one individual affected with hypertrophic cardiomyopathy, however, this individual carried a co-variant in a different gene with unknown clinical significance (PMID: 28790153). This variant has been identified in 1/231870 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
Hypertrophic cardiomyopathy 4;C3715165:Left ventricular noncompaction 10 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsJul 26, 2021- -
Cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingColor Diagnostics, LLC DBA Color HealthMar 16, 2023This missense variant replaces glycine with tryptophan at codon 5 of the MYBPC3 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in at least one individual affected with hypertrophic cardiomyopathy (PMID: 28790153, 32841044). This variant has been identified in 1/231870 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
Hypertrophic cardiomyopathy 4 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingMolecular Genetics, Royal Melbourne HospitalApr 22, 2022This sequence change is predicted to replace glycine with tryptophan at codon 5 of the MYBPC3 protein, p.(Gly5Trp). The glycine residue is weakly conserved (100 vertebrates, UCSC), and is not located in an annotated domain. There is a large physicochemical difference between glycine and tryptophan. The variant is present in a single individual in a large population cohort (rs201278114, 1/231,870 alleles, 0 homozygotes in gnomAD v2.1). The variant has been classified as a variant of uncertain significance (ClinVar ID: 217839), and has been identified in a case with hypertrophic cardiomyopathy with another variant in TNNT2 (PMID: 28790153). Multiple lines of computational evidence predict a benign effect for the missense substitution (4/5 algorithms). Based on the classification scheme RMH ACMG Guidelines v1.2.1, this variant is classified as a VARIANT OF UNCERTAIN SIGNIFICANCE. Following criteria are met: PM2. -
Hypertrophic cardiomyopathy 1 Uncertain:1
Uncertain significance, criteria provided, single submitterresearchAgnes Ginges Centre for Molecular Cardiology, Centenary InstituteJul 03, 2015This MYBPC3 Gly5Trp variant has not previously been reported in the general population or the literature. We have identified this variant in 1 HCM proband who also carries a second variant of uncertain significance in TNNT2 (Arg293Cys). This patient was diagnosed at 62 years and has a maximal wall thickness of 20mm. This variant is not present in the Exome Aggregation Consortium dataset (http://exac.broadinstitute.org/). Computational analyses (Polyphen2, CADD, SIFT, Grantham) support a potentially deleterious effect. More evidence and additional data is needed to confirm the role of this variant. Thus, we classify this variant as of "uncertain significance". -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.46
CardioboostCm
Benign
0.0068
BayesDel_addAF
Benign
-0.0039
T
BayesDel_noAF
Benign
-0.24
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Benign
0.22
T;T;T
Eigen
Benign
-0.027
Eigen_PC
Benign
0.0031
FATHMM_MKL
Benign
0.72
D
LIST_S2
Uncertain
0.90
D;D;D
M_CAP
Benign
0.085
D
MetaRNN
Benign
0.21
T;T;T
MetaSVM
Benign
-0.83
T
MutationAssessor
Benign
1.8
L;.;.
MutationTaster
Benign
0.97
D;D;D
PrimateAI
Uncertain
0.55
T
PROVEAN
Benign
-1.4
N;N;N
REVEL
Benign
0.080
Sift
Uncertain
0.029
D;D;D
Sift4G
Uncertain
0.026
D;D;D
Polyphen
0.88
P;.;.
Vest4
0.38
MutPred
0.36
Gain of catalytic residue at G5 (P = 0.0055);Gain of catalytic residue at G5 (P = 0.0055);Gain of catalytic residue at G5 (P = 0.0055);
MVP
0.74
MPC
0.64
ClinPred
0.93
D
GERP RS
4.5
Varity_R
0.20
gMVP
0.27

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs201278114; hg19: chr11-47374186; API